More
    Guided Solutions - Connecting Talent With Innovation/div>

    Clinical Trials

    Fitbit begins smartwatch blood pressure tracking study

    Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be...

    UroMems Completes €23 Million Series B Financing

    Further participation from existing investors raised additional €7 million Additional capital to fund initiation of the first clinical trial...

    Pixium Puts Second Sight in Rear View with Pivotal Trial

    Pixium’s PRIMAvera study is an open-label, baseline-controlled, nonrandomized, multi-center, prospective, single-arm confirmatory trial of the Prima System. The implant is a bionic...

    Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain

    Nevro touted results from a trial of its Senza system for treating painful diabetic neuropathy (PDN)-related chronic pain.

    Full results of EndeavorRx adjunct trial show longer benefits with or without stimulant therapy

    The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.

    Ava to commence trial of fertility tracker device for Covid-19 detection

    Ava, a digital healthcare company that focuses on women's reproductive health, has announced it will be launching the first study of its...

    Insulet’s Omnipod 5 trial shows benefits across patient groups with Type 1 diabetes

    Clinical trial results for Insulet's Omnipod 5 automated insulin pump system showed improvements across multiple metrics after three months of use for adult, adolescent...

    Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

    Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan® , the first and only patient-friendly, preparation-free, screening test to...

    BrainQ announces encouraging study results for new therapy to reduce disability after stroke

    Study presented 77% of the treatment group recovered to a level of no symptoms or no significant disability on the modified Rankin...

    Latest articles

    Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

    International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4...

    OncoSec Receives CE Mark Certification for its Commercial Electroporation Device “GenPulse™” for the Treatment of Solid Tumors

    CE mark enables commercialization of GenPulse™ in EU OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company"...

    Endologix acquires PQ Bypass to expand vascular product portfolio

    Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical needs of both...

    CeQur raises $115M for wearable insulin delivery device

    CeQur announced that it closed an oversubscribed equity financing round with proceeds of $115 million.
    59.5k Followers
    Follow